Opportunity

DIBBS #SPE2DP-26-T-3860

DLA Solicits Sumatriptan Succinate Tablets (100mg) from Approved OEMs

Posted

June 22, 2026

Respond By

June 29, 2026

Identifier

SPE2DP-26-T-3860

NAICS

325412

This opportunity is a pharmaceutical supply procurement by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - Primary contact: Vanesa M Carbo Acevedo - OEMs (Original Equipment Manufacturers): - MYLAN PHARMACEUTICALS INC - GOLDEN STATE MEDICAL SUPPLY, INC. - Vendors/Approved Sources: - MYLAN PHARMACEUTICALS INC (Part Number: NDC00378-5632-59) - GOLDEN STATE MEDICAL SUPPLY, INC. (Part Number: NDC51407-0013-09) - Products Requested: - Sumatriptan Succinate Tablets, 100mg, bottles of 9 tablets - NSN: 6505-01-727-8704 - Quantity: 5 units - Indicated for acute treatment of migraine with or without aura in adults - Must have a 24-month non-extendable shelf life - Packaging per MIL-STD-2073-1E and MIL-STD-129 - Storage: 20 to 25°C (68 to 77°F), protect from light - Notable Requirements: - Delivery required within 5 days after award to JBER, Alaska - Compliance with domestic sourcing laws - Prohibition on covered defense telecommunications equipment - Fast award process

Description

SUMATRIPTAN SUCCINA (QTY: 5, NSN: 6505-01-727-8704, Purchase Request: 7017223555) Approved Sources: - CAGE: 1HT23, Part No: NDC51407-0013-09, Company: GOLDEN STATE MEDICAL SUPPLY, INC. - CAGE: 3KJG9, Part No: NDC00378-5632-59, Company: MYLAN PHARMACEUTICALS INC

View original listing